Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$677,600
+$75,200 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#369
of 671 holders
Holding Since
Sep 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RBF Capital, LLC holds $1,716,600 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (39.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRGO |
PERRIGO Co plc
|
100,000 | $1,039,000 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
20,000 | $677,600 |
All Filings in TEVA
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $677,600 | 20,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $602,400 | 20,000 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,560,500 | 50,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,010,000 | 50,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $838,000 | 50,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $768,500 | 50,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,102,000 | 50,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,621,800 | 90,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,462,500 | 90,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,411,000 | 100,000 | Shares | Sole | 2024-05-15 | |
| 2022-09-30 | $564,900 | 70,000 | Shares | Sole | 2022-11-14 | |
| 2020-09-30 | $360,400 | 40,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||